Eli Lilly and Co. (NYSE:
LLY) has recently launched the very first insulin pen with memory -
HumaPen® MEMOIR™ - to help simplify the daily management of diabetes.
MEMOIR is designed to meet the needs of people with diabetes who take several shots of mealtime insulin each day. It presents sophisticated technology and features in a consumer-friendly "push-to-know" digital display that allows patients to record and review their last 16 insulin doses, including the priming doses.
HumaPen® MEMOIR™ is available by prescription in pharmacies nationwide and is for use with Humalog® (insulin lispro injection [rDNA origin]) -- the most-prescribed mealtime insulin in the United States.
Find more details from the press release.
.jpg)
Comment Preview